Rabattvertragsausschreibungen in der Generikaindustrie in Deutschland: Auswirkungen auf Marktstruktur, Anbietervielfalt und Wettbewerb

Cosima Bauer; Matthias Hunold; Kai Hüschelrath; Rebecca Jahn; Marco Kotschedoff; Ulrich Laitenberger; Gerald Lux; Uwe May; Anke Walendzik; Jürgen Wasem; Lennart Weegen

doi:10.5771/9783845260655

Rabattvertragsausschreibungen in der Generikaindustrie in Deutschland: Auswirkungen auf Marktstruktur, Anbietervielfalt und Wettbewerb

Translated title of the contribution: Rebate contract tenders in the generics industry in Germany: Effects on market structure, supplier diversity and competition

Cosima Bauer, Matthias Hunold, Kai Hüschelrath, Rebecca Jahn, Marco Kotschedoff, Ulrich Laitenberger, Gerald Lux, Uwe May, Anke Walendzik, Jürgen Wasem, Lennart Weegen

Research output: Book/Report › Book › Scientific

Abstract

Since 2003, health insurance funds have been able to agree discounts on medicines with pharmaceutical companies. In the generics sector in particular, the conclusion of corresponding discount agreements has since developed into an important cost-saving instrument for health insurance funds. For generics manufacturers, discount agreements have led to a structural change in demand, as it is no longer primarily doctors, pharmacists and patients who choose the medication. Instead, the health insurance funds make far-reaching decisions about the distribution of demand among manufacturers by structuring the tendering process for discount agreements and selecting the contractual partners. Against this background, the study examines the effects of discount agreements on the generics industry in Germany with a particular focus on market structure, supplier diversity and competition. It also examines the causalities between legal changes that have been made since 2009, particularly in procurement and competition law, and changes in tendering practices on the one hand and the market structure on the other.

Translated with DeepL.com (free version)

Translated title of the contribution	Rebate contract tenders in the generics industry in Germany: Effects on market structure, supplier diversity and competition
Original language	German
Place of Publication	Baden-Baden
Publisher	Nomos Verlagsgesellschaft mbH & Co. KG
Volume	104
ISBN (Print)	978-3-8452-6065-5
DOIs	https://doi.org/10.5771/9783845260655
Publication status	Published - 2015
Externally published	Yes

Publication series

Name	ZEW Wirtschaftsanalysen - Schriftenreihe des ZEW
Volume	104

Access to Document

10.5771/9783845260655

Cite this

Bauer, C., Hunold, M., Hüschelrath, K., Jahn, R., Kotschedoff, M., Laitenberger, U., Lux, G., May, U., Walendzik, A., Wasem, J., & Weegen, L. (2015). Rabattvertragsausschreibungen in der Generikaindustrie in Deutschland: Auswirkungen auf Marktstruktur, Anbietervielfalt und Wettbewerb. (ZEW Wirtschaftsanalysen - Schriftenreihe des ZEW; Vol. 104). Nomos Verlagsgesellschaft mbH & Co. KG. https://doi.org/10.5771/9783845260655

@book{a79548baac7643898cbda619f02b5c9b,

title = "Rabattvertragsausschreibungen in der Generikaindustrie in Deutschland: Auswirkungen auf Marktstruktur, Anbietervielfalt und Wettbewerb",

abstract = "Since 2003, health insurance funds have been able to agree discounts on medicines with pharmaceutical companies. In the generics sector in particular, the conclusion of corresponding discount agreements has since developed into an important cost-saving instrument for health insurance funds. For generics manufacturers, discount agreements have led to a structural change in demand, as it is no longer primarily doctors, pharmacists and patients who choose the medication. Instead, the health insurance funds make far-reaching decisions about the distribution of demand among manufacturers by structuring the tendering process for discount agreements and selecting the contractual partners. Against this background, the study examines the effects of discount agreements on the generics industry in Germany with a particular focus on market structure, supplier diversity and competition. It also examines the causalities between legal changes that have been made since 2009, particularly in procurement and competition law, and changes in tendering practices on the one hand and the market structure on the other.Translated with DeepL.com (free version)",

author = "Cosima Bauer and Matthias Hunold and Kai H{\"u}schelrath and Rebecca Jahn and Marco Kotschedoff and Ulrich Laitenberger and Gerald Lux and Uwe May and Anke Walendzik and J{\"u}rgen Wasem and Lennart Weegen",

year = "2015",

doi = "10.5771/9783845260655",

language = "German",

isbn = "978-3-8452-6065-5",

volume = "104",

series = "ZEW Wirtschaftsanalysen - Schriftenreihe des ZEW",

publisher = "Nomos Verlagsgesellschaft mbH & Co. KG",

address = "Germany",

}

Bauer, C, Hunold, M, Hüschelrath, K, Jahn, R, Kotschedoff, M, Laitenberger, U, Lux, G, May, U, Walendzik, A, Wasem, J & Weegen, L 2015, Rabattvertragsausschreibungen in der Generikaindustrie in Deutschland: Auswirkungen auf Marktstruktur, Anbietervielfalt und Wettbewerb. ZEW Wirtschaftsanalysen - Schriftenreihe des ZEW, vol. 104, vol. 104, Nomos Verlagsgesellschaft mbH & Co. KG, Baden-Baden. https://doi.org/10.5771/9783845260655

TY - BOOK

T1 - Rabattvertragsausschreibungen in der Generikaindustrie in Deutschland: Auswirkungen auf Marktstruktur, Anbietervielfalt und Wettbewerb

AU - Bauer, Cosima

AU - Hunold, Matthias

AU - Hüschelrath, Kai

AU - Jahn, Rebecca

AU - Kotschedoff, Marco

AU - Laitenberger, Ulrich

AU - Lux, Gerald

AU - May, Uwe

AU - Walendzik, Anke

AU - Wasem, Jürgen

AU - Weegen, Lennart

PY - 2015

Y1 - 2015

N2 - Since 2003, health insurance funds have been able to agree discounts on medicines with pharmaceutical companies. In the generics sector in particular, the conclusion of corresponding discount agreements has since developed into an important cost-saving instrument for health insurance funds. For generics manufacturers, discount agreements have led to a structural change in demand, as it is no longer primarily doctors, pharmacists and patients who choose the medication. Instead, the health insurance funds make far-reaching decisions about the distribution of demand among manufacturers by structuring the tendering process for discount agreements and selecting the contractual partners. Against this background, the study examines the effects of discount agreements on the generics industry in Germany with a particular focus on market structure, supplier diversity and competition. It also examines the causalities between legal changes that have been made since 2009, particularly in procurement and competition law, and changes in tendering practices on the one hand and the market structure on the other.Translated with DeepL.com (free version)

AB - Since 2003, health insurance funds have been able to agree discounts on medicines with pharmaceutical companies. In the generics sector in particular, the conclusion of corresponding discount agreements has since developed into an important cost-saving instrument for health insurance funds. For generics manufacturers, discount agreements have led to a structural change in demand, as it is no longer primarily doctors, pharmacists and patients who choose the medication. Instead, the health insurance funds make far-reaching decisions about the distribution of demand among manufacturers by structuring the tendering process for discount agreements and selecting the contractual partners. Against this background, the study examines the effects of discount agreements on the generics industry in Germany with a particular focus on market structure, supplier diversity and competition. It also examines the causalities between legal changes that have been made since 2009, particularly in procurement and competition law, and changes in tendering practices on the one hand and the market structure on the other.Translated with DeepL.com (free version)

U2 - 10.5771/9783845260655

DO - 10.5771/9783845260655

M3 - Book

SN - 978-3-8452-6065-5

VL - 104

T3 - ZEW Wirtschaftsanalysen - Schriftenreihe des ZEW

BT - Rabattvertragsausschreibungen in der Generikaindustrie in Deutschland: Auswirkungen auf Marktstruktur, Anbietervielfalt und Wettbewerb

PB - Nomos Verlagsgesellschaft mbH & Co. KG

CY - Baden-Baden

ER -

Rabattvertragsausschreibungen in der Generikaindustrie in Deutschland: Auswirkungen auf Marktstruktur, Anbietervielfalt und Wettbewerb

Abstract

Publication series

Access to Document

Fingerprint

Cite this